Antiobesity Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033
The Business Research Company has updated all its market reports with the latest information for the year 2024, projecting trends and forecasts until 2033
— The Business Research Company
LONDON, GREATER LONDON, UNITED KINGDOM, October 30, 2024 /EINPresswire.com/ — The Business Research Company’s Early Year-End Sale! Get up to 30% off detailed market research reports—limited time only!
The antiobesity market has experienced rapid growth in recent years, projected to rise from $3.38 billion in 2023 to $3.76 billion in 2024, with a compound annual growth rate (CAGR) of 11.3%. This growth during the historical period can be attributed to the rising prevalence of obesity, increased awareness and education, lifestyle changes, and government initiatives.
How Big Is the Global Antiobesity Market Expected to Grow, and What Is Its Annual Growth Rate?
The antiobesity market is anticipated to experience rapid growth in the coming years, reaching $5.64 billion by 2028 at a compound annual growth rate (CAGR) of 10.7%. This growth during the forecast period can be linked to market expansion and globalization.
Uncover In-Depth Analysis of the Global Antiobesity Market by Accessing a Sample Report:
What Is Driving the Growth of the Antiobesity Market?
The increasing geriatric population is projected to drive the growth of the anti-obesity drugs market in the future. The geriatric population consists of older individuals, typically those aged 65 and above. Anti-obesity drugs are a significant concern among seniors, especially those with diabetes, as they are more prone to obesity due to decreased physical activity and reduced blood circulation throughout the body.
Pre-book the report for a swift delivery:
Which Leading Companies Are Driving The Growth Of The Antiobesity Market Share?
Key players in the antiobesity market include F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Pfizer Inc., Merck & Co. Inc., Takeda Pharmaceutical Company Limited, Eisai Co. Ltd., Novo Nordisk A/S, Zafgen Inc., Rhythm Pharmaceuticals Inc., Zydus Cadila, Norgine B.V., Vivus Inc., Arena Pharmaceuticals Inc., Orexigen Therapeutics Inc., Eli Lilly and Company, Amgen Inc., AstraZeneca PLC, Novartis International AG, Viking Therapeutics Inc., Structure Therapeutics Inc., Gelesis Inc., Sanofi S.A., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Limited, Allergan Aesthetics, Sun Pharmaceutical Industries Ltd.,
What Are The Key Trends Driving The Growth Of The Antiobesity Market Size?
Leading companies in the anti-obesity drugs market are concentrating on developing innovative products, such as Mounjaro (tirzepatide), to offer dependable services to their customers. Mounjaro (tirzepatide) is utilized as an anti-obesity treatment for adults dealing with obesity or overweight issues, particularly when associated with weight-related comorbidities.
How Is the Global Antiobesity Market Segmented?
1) By Drug Class: Peripherally acting anti obesity drugs, Centrally acting anti obesity drugs
2) By Type: Prescription Drugs (Rx), OTC Drugs
3) By Medication: Monotherapies, Polytherapies
North America: The Leading Region in the Antiobesity Market
North America was the largest region in the anti-obesity market in 2023. Middle East is expected to be the fastest-growing region in the market. The regions covered in the market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Is the Antiobesity Market?
Anti-obesity drugs are medications designed to reduce or regulate a patient’s weight. These drugs work by affecting one of the body’s fundamental functions related to weight control, either by influencing appetite or altering calorie absorption. While these medications can be beneficial, dieting (through a healthy diet and caloric restriction) and exercise remain the primary therapeutic strategies for individuals who are overweight or obese.
The Antiobesity Global Market Report 2024 from The Business Research Company includes the following key information:
• Market size data for both historical and future periods
• Analysis of both macro and microeconomic factors that have impacted the market over the past five years
• Regional market analysis covering Asia-Pacific, China, Western Europe, Eastern Europe, North America, the USA, South America, and the Middle East and Africa
• Country-specific market analysis for Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.
Overview of the Global Antiobesity Market Report: Trends, Opportunities, Strategies, and More
The Antiobesity Global Market Report 2024 from The Business Research Company is an extensive resource that delivers insights into antiobesity market size, antiobesity market drivers and trends, antiobesity competitors’ revenues, and antiobesity market growth across geographies. This report provides valuable in-depth insights into potential opportunities and strategies. Companies can utilize the information presented to target segments with the greatest growth potential.
Browse Through More Similar Reports By The Business Research Company:
Smart Pills Global Market Report 2024
Medical Foods Global Market Report 2024
Smart Healthcare Products Global Market Report 2024
What Services Does The Business Research Company Offer?
The Business Research Company has published more than 15,000 reports spanning 27 industries and over 60 regions. Our research is supported by 1.5 million datasets, thorough secondary research, and unique insights gained from interviews with industry experts. We offer ongoing and customized research services, featuring a variety of specialized packages designed to meet your specific needs, such as Market Entry Research, Competitor Tracking, Supplier & Distributor Packages, and many others.
Our flagship product, the Global Market Model, serves as a leading market intelligence platform that provides comprehensive and updated forecasts to facilitate informed decision-making
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Article originally published on www.einpresswire.com as Antiobesity Global Market 2024 To Reach $5.64 Billion By 2028 At Rate Of 10.7%
